Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1447782Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1490814Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1529385Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1564713Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1665083Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1713247Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1789052Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1813697Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1920680Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1923656Peak areaCase N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1932331Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1937669Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1947948Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1947983Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1978974Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-1999908Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2026256Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2026500Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2034254Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2063668Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2067748Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2071105Peak areaControl N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2078077Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2079743Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2084412Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2094162Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2105098Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2114709Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2125303Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2132534Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2165749Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2169200Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2171793Peak areaControl Y Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2173125Peak areaCase N Exemestane Black Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2184157Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2191249Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2193723Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2223226Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2226260Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2228354Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2234882Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2235847Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2238061Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2240160Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2243439Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2256038Peak areaControl N Exemestane Black Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2281924Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2283374Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2283591Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2311217Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2314794Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2329935Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2335523Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2369144Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2379806Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2401273Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2419412Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2419943Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2425832Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2446516Peak areaCase N Exemestane Black 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2448511Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2488022Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2491541Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2497653Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2508460Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2531716Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2533568Peak areaControl N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2573247Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2578726Peak areaControl N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2593117Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2596010Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2605712Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2622519Peak areaControl N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2705807Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2717994Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2736164Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2746039Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2751415Peak areaCase N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2773770Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2782676Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2802988Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2818519Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2844981Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2864140Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2871171Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2895611Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2897045Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2952106Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-2972038Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3050464Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3113558Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3118327Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3173099Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3269963Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3287453Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3517766Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3528709Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3587423Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3873913Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODELINOLEATE (CAS# 60-33-3); (M-H)-3886212Peak areaCase Y Exemestane White Baseline N Y

Return to search page
  logo